Therapeutic Potential of Bioactive Compounds of Prunus Laurocerasus in the Management of Metabolic Syndrome
The Eurasia Proceedings of Science, Technology, Engineering and Mathematics · 2026-07-31 · 40 ((Early Pub)) · 28-36
DOI: 10.55549/epstem.1424 ↗At a glance
Journal article in The Eurasia Proceedings of Science, Technology, Engineering and Mathematics, published online on 2026-07-31. Written by Eteri Margalitadze and 4 co-authors. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
Obesity and overweight are major global health concerns and it is obvious, that the trend of the cases is growing over time. These states are closely linked to type 2 diabetes mellitus, cardiovascular disease, hypertension, heart failure with preserved ejection fraction and various malignancies. Excess adiposity promotes insulin resistance, chronic inflammation, dyslipidemia, endothelial dysfunction, and neurohormonal activation. Growing interest in natural product–based therapeutics has highlighted polyphenol-rich plant extracts as potential adjunctive strategies for metabolic regulation. Cherry laurel (Prunus laurocerasus) is a polyphenol-rich fruit containing bioactive compounds such as quercetin, kaempferol, chlorogenic acid, and anthocyanins with reported anti-obesity effects.
Methods
Extracts of fresh, frozen, and dried Prunus laurocerasus fruits, collected from different regions of Georgia were analyzed for polyphenolic content. The biological activities of the identified bioactive compounds were contextualized based on previously published preclinical studies evaluating their effects on adipogenesis, lipid metabolism, glucose homeostasis, inflammatory signaling and energy regulation.
Results
All extracts demonstrated consistently high polyphenolic content regardless of processing method or geographic origin. Chlorogenic acid and anthocyanins were identified as the predominant constituents, followed by substantial levels of quercetin and comparatively lower concentrations of kaempferol.
Conclusion
The polyphenolic profile of Prunus laurocerasus suggests its potential as a multifaceted adjunctive strategy in metabolic syndrome management, warranting further translational and clinical investigation.
Cite
APA
Margalitadze, E., Surmanidze, N., Japaridze, I., Vanidze, M., & Kalandia, A. (2026). Therapeutic Potential of Bioactive Compounds of Prunus Laurocerasus in the Management of Metabolic Syndrome. The Eurasia Proceedings of Science, Technology, Engineering and Mathematics, 40((Early Pub)), 28-36. https://doi.org/10.55549/epstem.1424
Vancouver
Margalitadze E, Surmanidze N, Japaridze I, Vanidze M, Kalandia A. Therapeutic Potential of Bioactive Compounds of Prunus Laurocerasus in the Management of Metabolic Syndrome. The Eurasia Proceedings of Science, Technology, Engineering and Mathematics. 2026;40((Early Pub)):28-36. doi:10.55549/epstem.1424
BibTeX
@article{Margalitadze2026,
author = {Margalitadze, Eteri and Surmanidze, Nona and Japaridze, Indira and Vanidze, Maia and Kalandia, Aleko},
title = {Therapeutic Potential of Bioactive Compounds of Prunus Laurocerasus in the Management of Metabolic Syndrome},
journal = {The Eurasia Proceedings of Science, Technology, Engineering and Mathematics},
year = {2026},
volume = {40},
number = {(Early Pub)},
pages = {28--36},
doi = {10.55549/epstem.1424}
}
EUVIMED